Phase II Randomized Study of Gemcitabine and Cisplatin With Malignant Mesothelioma
Phase II Randomized Study of Gemcitabine and Cisplatin With or Without Bevacizumab
in Patients With Malignant Mesothelioma
Background:
Drugs used in chemotherapy use different ways to stop tumor cells from dividing
so they stop growing or die. Monoclonal antibodies such as bevacizumab can locate
tumor cells and kill them without harming normal cells. It is not yet known if combination
chemotherapy is more effective with or without bevacizumab in treating malignant
mesothelioma. This is a Randomized phase II trial to compare the effectiveness of
combination chemotherapy with or without bevacizumab in treating patients who have
malignant mesothelioma.
Location/Contacts:
University of Chicago Cancer Research Center
Hedy L. Kindler, MD, Protocol Chair
Ph: 773-702-0360; 1-888-824-0200
California
Duarte
City of Hope Comprehensive Cancer Center
Marianna Koczywas, MD
Ph: 626-359-8111
1-800-826-4673
mkocywas@coh.org
Pasadena
City of Hope Medical Group
Mark V. McNamara, MD
Ph: 626-396-2900
mmcnmara@ccsmg.com
Sacramento
University of California Davis Cancer Center
David R. Gandara, MD
Ph: 916-734-3772
dgandara@cc.ucdmc.ucdavis.edu
Illinois
Chicago
Louis A. Weiss Memorial Hospital
Gary D. Steinberg, MD
Ph: 773-564-5272
University of Chicago Cancer Research Center
Hedy L. Kindler, MD
Ph: 773-702-0360
1-888-824-0200
Decatur
Decatur Memorial Hospital Cancer Center Institute
James L. Wade, MD
Ph: 217-876-6603
Harvey
Ingalls Memorial Hospital
Mark F. Kozloff, MD
Ph: 708-333-2300.
Sulochana D. Yalavarthi, MD
Ph: 708-915-6620
LaGrange
LaGrange Memorial Hospital
James E. Hannigan, MD
Ph: 708-579-3418
Renee H. Jacobs, MD
Ph: 708-579-3418
Maywood
Loyola University Medical Center
Joseph I. Clark, MD
Ph: 708-327-3236
jclark@lumc.edu
Kathy S. Albain, MD
Ph: 708-327-3102
kalbain@lumc.edu
Peoria
Oncology/Hematology Associates of Central Illinois, P.C.
James A. Knost, MD, FACP
Ph: 309-672-5681
John W. Kugler, MD
Ph: 309-671-3605
Indiana
Fort Wayne
Fort Wayne Medical Oncology and Hematology, Inc.
David Frank Sciortino, MD
Ph: 219-484-8830
Sreenivasa Rao Nattam, MD
Ph: 219-484-8830
800-852-2333
ledgar@fwmoh.com
South Bend
CCOP-Northern Indiana CR Consortium
David Allen Taber, MD
Ph: 800-284-7370
Rafat H. Ansari, MD, FACP
Ph: 219-234-5123
Michigan
Saint Joseph
Lakeland Medical Center - St. Joseph
Eric Lester, MD
Ph: 616-982-4963
New York
New York
Memorial Sloan-Kettering Cancer Center
Lee M. Krug, MD
Ph: 212-639-8420
Pennsylvania
Philadelphia
University of Pennsylvania Cancer Center
James Stevenson, MD
Ph: 215-662-8756
Texan
Houston
University of Texas - MD Anderson Cancer Center
Charles Lu, MD
Ph: 713-792-6363
1-800-392-1611
